產(chǎn)品描述: | A-804598是一種選擇性的P2X7R拮抗劑。它對大鼠P2X7受體(IC50 = 10 nM)、小鼠P2X7受體(IC50 = 9 nM)和人源P2X7受體(IC50 = 11 nM)皆具有高親和力 |
靶點: |
rat P2X7R:9 nM; rat P2X7R:10 nM; human P2X7R:11 nM;P2XReceptor |
體外研究: |
A-804598是一種新型的、競爭性的、選擇性的拮抗劑,對大鼠、小鼠和人源P2X7受體都具有相同的高親和力,IC50分別為10 nM、9 nM和11 nM。A-804598還可有效地抑制激動劑刺激的分化THP-1細胞中(表達人源P2X7受體)IL-1β的釋放(IC50=8.5 nM)、Yo-Pro的攝?。↖C50=8.1 nM)。盡管A-840598在濃度高達100 μM時,可有效地阻止P2X7受體的激活,但它不能顯著地降低激動劑所誘發(fā)的由多種其他P2X和P2Y受體所介導(dǎo)的胞內(nèi)鈣濃度的變化。A-840598對其他大多數(shù)G蛋白偶聯(lián)受體、酶、轉(zhuǎn)運體和離子通道沒有活性或僅具有微弱活性(IC50>5-10 μM) |
體內(nèi)研究: |
在SOD1-G93A小鼠中通過A-804598的處理可抑制其腰椎脊髓處SQSTM1/p62的上調(diào) |
細胞實驗: |
Cell lines: SOD1-G93A primary microglia Concentrations: 10 μM Incubation Time: 15 min or 1 h Method: SOD1-G93A microglia are treated with 300 μM BzATP or 3 mM ATP for 15 min or 1 h with or without 10 μM A-804598 and subjected to western blotting and immunoreactions with anti-p-mTOR and anti-mTOR or anti-GAPDH. |
動物實驗: |
Animal Models: SOD1-G93A mice Dosages: 30 mg/kg Administration: i.p. |
參考文獻: |
1. Donnelly-Roberts DL, et al. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology. 2009, 56(1):223-9. 2. Fabbrizio P, et al. P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia. Front Cell Neurosci. 2017, 11:249. |
溶解性: |
Soluble in DMSO、Ethanol |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
3.171 ml |
15.854 ml |
31.709 ml |
5 mM |
0.634 ml |
3.171 ml |
6.342 ml |
10 mM |
0.317 ml |
1.585 ml |
3.171 ml |
50 mM |
0.063 ml |
0.317 ml |
0.634 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |